Duke Medical Archives Home Page
HC 57 Eastern North Carolina Oncological Society Dr. John Laszlo Series 1 Case Histories and Miscellaneous Materials HC57010101 ENCOS Charter HC57010102 ENCOS - Continuing Medical Education HC57010103 ENCOS Correspondence HC57010104 Eastern N.C. Oncology Grant Application HC57010105 ENCOS Membership HC57010106 ENCOS Minutes Agenda - 1977 HC57010107 ENCOS Minutes Agenda - 1978 HC57010108 ENCOS Minutes Agenda - 1979 HC57010109 ENCOS Minutes Agenda - 1980 HC57010110 ENCOS Minutes Agenda - 1981 HC57010111 ENCOS Minutes Agenda - 1982 HC57010112 Nomination For Membership Form HC57010113 ENCOS Officers and Committees HC57010114 ENCOS Roster HC57010115 Miscellaneous Maps, Mailing Lists HC57010201 ENCOS - Protocol Summaries, Lung Cancer HC57010202 ENCOS - Protocol Breast Adjuvant HC57010203 Metastatic Breast Cancer Protocol HC57010204 Breast Cancer/Protocols HC57010205-47 RESTRICTED: patient files, H-W HC57010248 Adjuvant Therapy of Non-Rectal Colonic Cancer - Protocol Completed 1/31/1978 HC57010249 Adjuvant Therapy of Non-Rectal Colonic Cancer - Protocol Completed 4/25/1978 HC57010250 Adjuvant Therapy of Rectal Cancer - 4/27/1978 HC57010251 Antineoplastic Agents HC57010252 Pilot Study of Intravenous Infusion of 5-Fluorouracil and Mitomycin-C Plus Vincristine Versus Intravenous Infusion of 5-Fluorouracil and Methyl CCNU Plus Vincristine in Colorectal Carcinoma With Metastasis to the Liver HC57010253 Addenda to ENCOS Lung Cancer Protocol HC57010254 Protocol Design - Dosage and Administration HC57010301 Head and Neck Tumors HC57010302 SEG Protocol CA. Nasopharynx HC57010303 Colorectal cancer - ENCOS Protocols HC57010304 Dukes B and C - Colon Cancer HC57010305 Adjuvant Therapy of Non-Rectal Colonic Cancer HC57010306 Adjuvant Therapy of Rectal Cancer HC57010307 Colorectal Cancer with Metastasis to Liver HC57010308 Protocol - Prostate Cancer HC57010309 Cooperative Oncology Groups a. Community Hospitals b. Community Oncologists Conducting Clinical Trials c. Comprehensive Cancer Centers d. Cooperative Oncology Groups HC57010310 Eastern North Carolina Oncology Society a. ENCOS Financial Statement b. ENCOS Membership c. ENCOS Upcoming Meetings HC57010311 ENCOS Attendance List HC57010312 Data Collection Letter HC57010313 Protocol: Adjuvant Rectal - General Information HC57010314 Protocol: Adjuvant Rectal - NCI and Institutional Approval HC57010315 Protocol: Adj. Rectal-Participating M.D.s HC57010316 Patient Information - Supplies and Equipment a. Non-Duke Physicians - Colorectal Protocol b. VA Program - Colorectal Protocol HC57010317 Patient Information - Supportive Therapy a. Patient Information - Re: Colorectal Protocol b. Supportive Therapy - Relaxation Therapy HC57010318 Adjuvant Therapy for Patients with Dukes B2 and C Rectal Cancer HC57010319 Protocol: Adjuvant Rectal HC57010320 Correspondence - Re: ENCOS Protocols a. Correspondence - Re: Lung Cancer Protocols b. Requests for Lung Cancer Protocols c. ENCOS Protocols: Institutional Approval HC57010321 ENCOS - Flow Sheets a. ENCOS Protocols - Miscellaneous Materials b. ENCOS Protocol Forms HC57010401 Correspondence - Rectal Protocol HC57010402-10 RESTRICTED: patient files, S-Z HC57010411 ACCTG Flow Sheet - Adjuvant Rectal Protocol HC57010412 NCCTG - Adjuvant Rectal Protocol Flow Sheet Code Keys HC57010413 Cancer Therapy a. Chemotherapy b. Immunotherapy c. Quackery d. Radiation e. Surgery f. Randomized Clinical Trials HC57010414 Confirmation of Randomization Form Letter HC57010415 GI Clinic and Conferences HC57010416 RESTRICTED: Duke Patients HC57010417 Duke GI Tumor Clinic a. Duke Hospital Charges b. GI Clinic Miscellaneous c. Clinic Protocol d. Duke Flaw Sheets e. Duke Telephone Numbers f. Duke Housestaff and Attendings g. GI Clinic Appointment Schedule Forms HC57010418 Colorectal Protocol Standard Forms: Originals HC57010419 Active GI Protocols a. Colorectal Protocol b. Protocol - Adj. Rectal c. Interferon in Metastatic Colorectal Cancer HC57010420 Southeastern Cooperative Study Group HC57010421 Protocol: Adjuvant Rectal Selected Information a. Abstract and Summary - Colorectal Protocol b. Rectal Protocol - Addendum c. Criteria of Performance Status d. Eligibility Criteria e. Schema & Therapy Plan f. Adj. Rectal Protocol HC57010501 Lung Cancer Protocols HC57010502 Protocol: SCCL Laszlo and Muscato 6/26/81 HC57010503 Relapsed Oat Cell ARA-C HC57010504 RESTRICTED: Oat Cell - On Study HC57010505 Inactive a. ENCOS Protocol #1 Adjuv. Non-Oat Cell b. ENCOS Protocol #2 Adjuv. Oat Cell Ca. c. ENCOS Protocol #3 Combin. Rx. for Mets. HC57010506 RESTRICTED: Non-Oat Cell #1 Complete HC57010507 RESTRICTED: Oat Cell Complete HC57010508 Duke Chemotherapy Treatment Program HC57010509 Guidelines for Randomizing HC57010510 Adj. Rectal Protocol Toxicity HC57010511 Patient Information - Duke Chemotherapy HC57010512 Patient Information - How to get to Duke HC57010513 Patient Information - Radiation Therapy HC57010514 Protocol: Adj. Rectal - Correspondence